Correction to “Fisetin, an Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-κB-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products through the Suppression of TAK-1 and Receptor-Interacting Protein-Regulated IκBα Kinase Activation”

doi:10.1124/mol.81.6.856

See original article:

Fisetin, an Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-κB-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products through the Suppression of TAK-1 and Receptor-Interacting Protein-Regulated IκBα Kinase Activation - June 01, 2007

In the above article [Sung B, Mandey MK, and Aggarwal BB (2007) Mol Pharmacol 71:1703–1714], the Fisetin structure presented in Fig. 1A was incorrect. The correct structure of Fisetin is shown below.

In addition, in the second paragraph of the article, in the sentence beginning “Fisetin (3,3′,4′,7-tetrahydroxyflavone) is a flavonoid …,” the concentration range stated is incorrect. The concentration should be “0.1 to 160 μg/g.”